Press Releases

SEATTLE, WA / ACCESSWIRE / June 3, 2024 / Aptevo Therapeutics Inc. (Nasdaq: APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR" and ADAPTIR-FLEX" platform technologies, today announced that the Company is participating in the BIO International Convention occurring June 3-6, 2024 in San Diego, CA.

The conference is known for being the largest biotechnology industry conference of the year... (continue reading...)

HOUSTON, TX / ACCESSWIRE / June 3, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced a 1-for-50 reverse split of its common stock, effective at 4:01 PM ET on June 4, 2024. Beginning on June 5, 2024, the Company's common stock will continue to trade on The Nasdaq Capital Market... (continue reading...)

Action Behavior Centers, Hearthside, Park Place, and Tecomet recognized for their commitment to prioritizing the emotional wellness of their employees

BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- Four portfolio companies of Charlesbank Capital Partners—Action Behavior Centers, Hearthside Food Solutions, Park Place and Tecomet—have been named to Newsweek’s list of "America’s Greatest Workplaces for Mental Wellbeing 2024." Newsweek partnered with data researcher... (continue reading...)

MCLEAN, Va., June 3, 2024 /PRNewswire/ -- V2X, Inc. (NYSE: VVX) announces it has successfully repriced and extended its $907 million First Lien Term Loan.

Under the repricing, the annual interest margin was reduced by 50 basis points to 2.75%. Additionally, the 10-basis point Credit Spread Adjustment was eliminated from the company's Secured Overnight... (continue reading...)

News Summary:

• Waters Xevo™ MRT Mass Spectrometer employs next-generation multi-reflecting time-of-flight technology to deliver class-leading combination of high resolution and speed without compromising analytical performance.i
• Delivers up to 6x resolution at maximum speed and up to 2x mass accuracy of competitive systems,ii enabling scientists to process more samples in less time for large-cohort biomedical research and epidemiology-type studies.
• Complete workflows... (continue reading...)